ong term opioid administration in oncologic chronic pain: open label, prospective study on efficacy, safety and pharmacogenetic factors. - ND
Active, not recruiting
- Conditions
- oncologic chronic painMedDRA version: 9.1Level: LLTClassification code 10058019Term: Cancer pain
- Registration Number
- EUCTR2008-002273-12-IT
- Lead Sponsor
- OSPEDALE POLICLINICO S. MATTEO
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
age > 18 years, oncologic, chronic, neurophatic and/or nocicettive periferic pain
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
abuse history, opioid analgesic use history, opioid allergies, ...
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: -to identify opioid product with the best clinical-pharmacological efficacy-safety profile<br>-to identify genetic polymorphism relatied to the best clinical response.;Secondary Objective: to evaluate opioid pharmacokinetic;Primary end point(s): pain reduction at least 40% in VAS scale
- Secondary Outcome Measures
Name Time Method